Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease

Cytokine

Volumn 58, Issue 3, 2012, Pages 336-343

  Kim, Hak Ryul ^a   Jun, Chang Duk ^b   Lee, Koung Sun ^a,c   Cho, Ji Hyun ^a,c   Jeong, Eun Taik ^a   Yang, Sei Hoon ^a   Lee, Young Jin ^a,c   Park, Do Sim ^a,c  

^a Wonkwang University   (South Korea)

^b Gwangju Institute of Science and Technology (GIST)   (South Korea)

^c Wonkwang University School of Medicine   (South Korea)

Author keywords

Chitinase like protein; Pleural effusion; Tuberculosis; YKL 39; YKL 40

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CHITINASE 3 LIKE PROTEIN 1; CHITINASE 3 LIKE PROTEIN 2; CYTOKERATIN 19 FRAGMENT; GLUCOSE; LACTATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LONGITUDINAL STUDY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PATIENT MONITORING; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; TUBERCULOSIS;

ADIPOKINES; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LECTINS; LUNG DISEASES; MALE; MIDDLE AGED; PLEURAL DISEASES; PLEURAL EFFUSION; PROSPECTIVE STUDIES;

EID: 84860344105     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.001     Document Type: Article

References (45)

1. Funkhouser J.D., Aronson N.N. Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol 2007, 7:96.
2. Sohn M.H., Kang M.J., Matsuura H., Bhandari V., Chen N.Y., Lee C.G., et al. The chitinase-like proteins breast regression protein-39 and YKL-40 regulate hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 2010, 182:918-928.
3. Hartl D., Lee C.G., Da Silva C.A., Chupp G.L., Elias J.A. Novel biomarkers in asthma: chemokines and chitinase-like proteins. Curr Opin Allergy Clin Immunol 2009, 9:60-66.
4. Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., et al. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med 2008, 358:1682-1691.
5. Chupp G.L., Lee C.G., Jarjour N., Shim Y.M., Holm C.T., He S., et al. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med 2007, 357:2016-2027.
6. Tang H., Fang Z., Sun Y., Li B., Shi Z., Chen J., et al. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E. Eur Respir J 2010, 35:757-760.
7. Létuvé S., Kozhich A., Arouche N., Grandsaigne M., Reed J., Dombret M.C., et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 2008, 181:5167-5173.
8. Furuhashi K., Suda T., Nakamura Y., Inui N., Hashimoto D., Miwa S., et al. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir Med 2010, 104:1204-1210.
9. Lee C.G., Da Silva C.A., Dela Cruz C.S., Ahangari F., Ma B., Kang M.J., et al. Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury. Annu Rev Physiol 2011, 73:479-501.
10. Zhu Z., Zheng T., Homer R.J., Kim Y.K., Chen N.Y., Cohn L., et al. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004, 304:1678-1682.
11. Kzhyshkowska J., Gratchev A., Goerdt S. Human chitinases and chitinase-like proteins as indicators for inflammation and cancer. Biomark Insights 2007, 2:128-146.
12. Thöm I., Andritzky B., Schuch G., Burkholder I., Edler L., Johansen J.S., et al. Elevated pretreatment serum concentration of YKL-40 - an independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer. Cancer 2010, 116:4114-4121.
13. Choi I.K., Kim Y.H., Kim J.S., Seo J.H. High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer. Acta Oncol 2010, 49:861-864.
14. Johansen J.S., Drivsholm L., Price P.A., Christensen I.J. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004, 46:333-340.
15. Hu B., Trinh K., Figueira W.F., Price P.A. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1996, 271:19415-19420.
16. Sekine T., Masuko-Hongo K., Matsui T., Asahara H., Takigawa M., Nishioka K., et al. Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 2001, 60:49-54.
17. Gratchev A., Schmuttermaier C., Mamidi S., Gooi L., Goerdt S., Kzhyshkowska J. Expression of osteoarthritis marker YKL-39 is stimulated by transforming growth factor beta (TGF-beta) and IL-4 in differentiating macrophages. Biomark Insights 2008, 3:39-44.
18. Ge Q., Moir L.M., Black J.L., Oliver B.G., Burgess J.K. TGFβ1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2/3. J Cell Physiol 2010, 225:846-854.
19. Chung C.L., Chen C.H., Sheu J.R., Chen Y.C., Chang S.C. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 2005, 128:690-697.
20. Lee J.I., Kim J.R., Jang T.J., Kim D.H. Expression of TGF-beta1 protein in macrophages of tuberculous granulomas. Korean J Pathol 1998, 32:261-265.
21. Lee C.G., Hartl D., Lee G.R., Koller B., Matsuura H., Da Silva C.A., et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med 2009, 206:1149-1166.
22. Bateman E.D., Boulet L.P., Cruz A., FitzGerald M., Haahtela T., Levy M., et al. Pocket guide for asthma management and prevention (for adults and children older than 5years). In: The global initiative for asthma 2010, p. 8-21.
23. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
24. Kiropoulos T.S., Kostikas K., Oikonomidi S., Tsilioni I., Nikoulis D., Germenis A., et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med 2007, 101:910-918.
25. Ferrer J., Villarino M.A., Encabo G., Felip E., Bermejo B., Vilà S., et al. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions. Cancer 1999, 86:1488-1495.
26. Romero S., Fernández C., Arriero J.M., Espasa A., Candela A., Martín C., et al. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Eur Respir J 1996, 9:17-23.
27. Daniil Z.D., Zintzaras E., Kiropoulos T., Papaioannou A.I., Koutsokera A., Kastanis A., et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J 2007, 30:957-964.
28. Park J.A., Drazen J.M., Tschumperlin D.J. The chitinase-like protein YKL-40 is secreted by airway epithelial cells at base line and in response to compressive mechanical stress. J Biol Chem 2010, 285:29817-29825.
29. Johansen J.S. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006, 53:172-209.
30. Kzhyshkowska J., Mamidi S., Gratchev A., Kremmer E., Schmuttermaier C., Krusell L., et al. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006, 107:3221-3228.
31. Nordenbaek C., Johansen J.S., Junker P., Borregaard N., Sørensen O., Price P.A. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis 1999, 180:1722-1726.
32. Sun X., Gulyás M., Hjerpe A. Mesothelial differentiation as reflected by differential gene expression. Am J Respir Cell Mol Biol 2004, 30:510-518.
33. Barnes P.F., Fong S.J., Brennan P.J., Twomey P.E., Mazumder A., Modlin R.L. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol 1990, 145:149-154.
34. Barnes P.F., Mistry S.D., Cooper C.L., Pirmez C., Rea T.H., Modlin R.L. Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989, 142:1114-1119.
35. Barnes P.F., Lu S., Abrams J.S., Wang E., Yamamura M., Modlin R.L. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993, 61:3482-3489.
36. Shimokata K., Saka H., Murate T., Hasegawa Y., Hasegawa T. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest 1991, 99:1103-1107.
37. Oshikawa K., Yanagisawa K., Ohno S., Tominaga S., Sugiyama Y. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 2002, 165:1005-1009.
38. Orphanidou D., Gaga M., Rasidakis A., Dimakou K., Toumbis M., Latsi P., et al. Tumour necrosis factor, interleukin-1 and adenosine deaminase in tuberculous pleural effusion. Respir Med 1996, 90:95-98.
39. Recklies A.D., Ling H., White C., Bernier S.M. Inflammatory cytokines induce production of CHI3L1 by articular chondrocytes. J Biol Chem 2005, 280:41213-41221.
40. Nielsen A.R., Plomgaard P., Krabbe K.S., Johansen J.S., Pedersen B.K. IL-6, but not TNF-α, increases plasma YKL-40 in human subjects. Cytokine 2011, 55:152-155.
41. Bojesen S.E., Johansen J.S., Nordestgaard B.G. Plasma YKL-40 levels in healthy subjects from the general population. Clin Chim Acta 2011, 412:709-712.
42. San José M.E., Valdés L., Vizcaíno L.H., Mora T., Pose A., Soneira E., et al. Procalcitonin C-reactive protein and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med 2010, 58:971-976.
43. Chierakul N., Kanitsap A., Chaiprasert A., Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004, 9:66-69.
44. Maeda J., Ueki N., Ohkawa T., Iwahashi N., Nakano T., Hada T., et al. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol 1993, 92:32-38.
45. Kastrup J. Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?. Immunobiology 2011, 10.1016/j.imbio.2011.04.007.